化疗栓塞-话题@MedSci

#化疗栓塞#

20篇内容 | 666人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1984608, encodeId=d7071984608d3, content=<a href='/topic/show?id=40d93356656' target=_blank style='color:#2F92EE;'>#化疗栓塞#</a>, objectTitle=J Clin Oncol：乐伐替尼联合经动脉化疗栓塞可显著改善晚期肝癌患者预后, objectType=article, longId=734441, objectId=ecbfe3444119, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ecbfe3444119, replyNumber=0, likeNumber=43, createdTime=2022-12-06, rootId=0, userName=ms5822920152752585, userId=6bf82500013, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ecbfe3444119, moduleTitle=J Clin Oncol：乐伐替尼联合经动脉化疗栓塞可显著改善晚期肝癌患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ecbfe3444119)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984603, encodeId=42c71984603de, content=<a href='/topic/show?id=40d93356656' target=_blank style='color:#2F92EE;'>#化疗栓塞#</a>, objectTitle=Eur J Cancer：采用顺铂或表柔比星进行动脉化疗栓塞治疗肝癌的疗效, objectType=article, longId=218192, objectId=0a32218192bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a32218192bf, replyNumber=0, likeNumber=43, createdTime=2022-08-30, rootId=0, userName=ms5822920152752585, userId=6bf82500013, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a32218192bf, moduleTitle=Eur J Cancer：采用顺铂或表柔比星进行动脉化疗栓塞治疗肝癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a32218192bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984605, encodeId=16a41984605c4, content=<a href='/topic/show?id=40d93356656' target=_blank style='color:#2F92EE;'>#化疗栓塞#</a>, objectTitle=JGH：肿瘤负荷评分可以作为肝细胞癌患者接受经动脉化疗栓塞术的新预后标志物, objectType=article, longId=292063, objectId=557f29206341, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=557f29206341, replyNumber=0, likeNumber=58, createdTime=2022-09-28, rootId=0, userName=ms5822920152752585, userId=6bf82500013, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=557f29206341, moduleTitle=JGH：肿瘤负荷评分可以作为肝细胞癌患者接受经动脉化疗栓塞术的新预后标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=557f29206341)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984607, encodeId=5c01198460e9b, content=<a href='/topic/show?id=40d93356656' target=_blank style='color:#2F92EE;'>#化疗栓塞#</a>, objectTitle=Liver Cancer：仑伐替尼联合或不联合药物洗脱微球经动脉化疗栓塞治疗不可切除晚期肝细胞癌的疗效, objectType=article, longId=300542, objectId=048f300542db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=048f300542db, replyNumber=0, likeNumber=36, createdTime=2022-10-27, rootId=0, userName=ms5822920152752585, userId=6bf82500013, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=048f300542db, moduleTitle=Liver Cancer：仑伐替尼联合或不联合药物洗脱微球经动脉化疗栓塞治疗不可切除晚期肝细胞癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=048f300542db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984604, encodeId=66981984604bd, content=<a href='/topic/show?id=40d93356656' target=_blank style='color:#2F92EE;'>#化疗栓塞#</a>, objectTitle=更新！看更新版《中国肝细胞癌经动脉化疗栓塞治疗临床实践指南》谈接受介入治疗的HCC患者抗HBV治疗, objectType=article, longId=219167, objectId=456221916eb9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=456221916eb9, replyNumber=0, likeNumber=48, createdTime=2022-08-19, rootId=0, userName=ms5822920152752585, userId=6bf82500013, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=456221916eb9, moduleTitle=更新！看更新版《中国肝细胞癌经动脉化疗栓塞治疗临床实践指南》谈接受介入治疗的HCC患者抗HBV治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=456221916eb9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984606, encodeId=dac819846066a, content=<a href='/topic/show?id=40d93356656' target=_blank style='color:#2F92EE;'>#化疗栓塞#</a>, objectTitle=Liver Cancer：Lenvatinib(仑伐替尼)初始治疗出现应答是仑伐替尼（LEN)+经动脉化疗栓塞(LEN-TACE)序贯治疗的预后指标, objectType=article, longId=299284, objectId=0f55299284f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f55299284f7, replyNumber=0, likeNumber=36, createdTime=2022-11-24, rootId=0, userName=ms5822920152752585, userId=6bf82500013, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f55299284f7, moduleTitle=Liver Cancer：Lenvatinib(仑伐替尼)初始治疗出现应答是仑伐替尼（LEN)+经动脉化疗栓塞(LEN-TACE)序贯治疗的预后指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f55299284f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984602, encodeId=ec64198460272, content=<a href='/topic/show?id=40d93356656' target=_blank style='color:#2F92EE;'>#化疗栓塞#</a>, objectTitle=Eur Radiol：肝癌累及了肝静脉或下腔静脉，经动脉化疗栓塞后总生存率怎么样？, objectType=article, longId=205353, objectId=2154205353fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2154205353fe, replyNumber=0, likeNumber=53, createdTime=2021-12-18, rootId=0, userName=ms5822920152752585, userId=6bf82500013, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2154205353fe, moduleTitle=Eur Radiol：肝癌累及了肝静脉或下腔静脉，经动脉化疗栓塞后总生存率怎么样？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2154205353fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984601, encodeId=fd48198460119, content=<a href='/topic/show?id=40d93356656' target=_blank style='color:#2F92EE;'>#化疗栓塞#</a>, objectTitle=Clinica Chimica Acta：可溶性程序性死亡配体1水平升高表明肝细胞癌患者接受经导管动脉化疗栓塞后免疫抑制和预后不良, objectType=article, longId=205304, objectId=1adf20530443, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1adf20530443, replyNumber=0, likeNumber=34, createdTime=2021-02-06, rootId=0, userName=ms5822920152752585, userId=6bf82500013, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1adf20530443, moduleTitle=Clinica Chimica Acta：可溶性程序性死亡配体1水平升高表明肝细胞癌患者接受经导管动脉化疗栓塞后免疫抑制和预后不良, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1adf20530443)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984600, encodeId=96381984600ce, content=<a href='/topic/show?id=40d93356656' target=_blank style='color:#2F92EE;'>#化疗栓塞#</a>, objectTitle=TAG: 辅助性经导管动脉化疗栓塞术在肝癌肝切除患者中的有效性分析, objectType=article, longId=204159, objectId=a3d420415962, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3d420415962, replyNumber=0, likeNumber=43, createdTime=2021-02-14, rootId=0, userName=ms5822920152752585, userId=6bf82500013, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3d420415962, moduleTitle=TAG: 辅助性经导管动脉化疗栓塞术在肝癌肝切除患者中的有效性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3d420415962)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984599, encodeId=a4011984599fc, content=<a href='/topic/show?id=40d93356656' target=_blank style='color:#2F92EE;'>#化疗栓塞#</a>, objectTitle=Brit J Surg：肝细胞癌患者经动脉化疗栓塞术后的肝移植结局 , objectType=article, longId=191083, objectId=eb51191083cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb51191083cc, replyNumber=0, likeNumber=33, createdTime=2020-08-22, rootId=0, userName=ms5822920152752585, userId=6bf82500013, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb51191083cc, moduleTitle=Brit J Surg：肝细胞癌患者经动脉化疗栓塞术后的肝移植结局 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb51191083cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984598, encodeId=59ce198459813, content=<a href='/topic/show?id=40d93356656' target=_blank style='color:#2F92EE;'>#化疗栓塞#</a>, objectTitle=Clinica Chimica Acta：新辅助介入化疗栓塞后宫颈鳞癌基因表达的变化, objectType=article, longId=177249, objectId=4e571e72490e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e571e72490e, replyNumber=0, likeNumber=36, createdTime=2020-06-02, rootId=0, userName=ms5822920152752585, userId=6bf82500013, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e571e72490e, moduleTitle=Clinica Chimica Acta：新辅助介入化疗栓塞后宫颈鳞癌基因表达的变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e571e72490e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984597, encodeId=89c0198459e64, content=<a href='/topic/show?id=40d93356656' target=_blank style='color:#2F92EE;'>#化疗栓塞#</a>, objectTitle=中国肝细胞癌经动脉化疗栓塞治疗（TACE）临床实践指南, objectType=article, longId=158247, objectId=bb4b15824eb7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb4b15824eb7, replyNumber=0, likeNumber=30, createdTime=2019-03-27, rootId=0, userName=ms5822920152752585, userId=6bf82500013, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb4b15824eb7, moduleTitle=中国肝细胞癌经动脉化疗栓塞治疗（TACE）临床实践指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb4b15824eb7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984596, encodeId=0347198459693, content=<a href='/topic/show?id=40d93356656' target=_blank style='color:#2F92EE;'>#化疗栓塞#</a>, objectTitle=Hepatology：在中-晚期肝癌患者中，肝切除和化疗栓塞两种治疗方法的比较, objectType=article, longId=149807, objectId=315514980e34, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=315514980e34, replyNumber=0, likeNumber=0, createdTime=2019-09-09, rootId=0, userName=ms5822920152752585, userId=6bf82500013, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=315514980e34, moduleTitle=Hepatology：在中-晚期肝癌患者中，肝切除和化疗栓塞两种治疗方法的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=315514980e34)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984593, encodeId=245319845934d, content=<a href='/topic/show?id=40d93356656' target=_blank style='color:#2F92EE;'>#化疗栓塞#</a>, objectTitle=CLIN CANCER RES：HBV相关肝细胞癌切除后辅助动脉化疗栓塞治疗, objectType=article, longId=137695, objectId=fe5a13e695b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe5a13e695b1, replyNumber=0, likeNumber=36, createdTime=2018-07-03, rootId=0, userName=ms5822920152752585, userId=6bf82500013, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe5a13e695b1, moduleTitle=CLIN CANCER RES：HBV相关肝细胞癌切除后辅助动脉化疗栓塞治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe5a13e695b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984595, encodeId=78e21984595fd, content=<a href='/topic/show?id=40d93356656' target=_blank style='color:#2F92EE;'>#化疗栓塞#</a>, objectTitle=中国肝细胞癌经动脉化疗栓塞治疗临床实践指南发布, objectType=article, longId=141151, objectId=38d214115123, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38d214115123, replyNumber=0, likeNumber=43, createdTime=2018-11-07, rootId=0, userName=ms5822920152752585, userId=6bf82500013, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38d214115123, moduleTitle=中国肝细胞癌经动脉化疗栓塞治疗临床实践指南发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38d214115123)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984594, encodeId=d4d61984594cf, content=<a href='/topic/show?id=40d93356656' target=_blank style='color:#2F92EE;'>#化疗栓塞#</a>, objectTitle=肝癌化疗栓塞后溶瘤综合征1例, objectType=article, longId=140122, objectId=34c8140122fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34c8140122fa, replyNumber=0, likeNumber=51, createdTime=2019-01-10, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34c8140122fa, moduleTitle=肝癌化疗栓塞后溶瘤综合征1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34c8140122fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984591, encodeId=d8a7198459168, content=<a href='/topic/show?id=40d93356656' target=_blank style='color:#2F92EE;'>#化疗栓塞#</a>, objectTitle=Radiology：肝细胞肝癌消融化疗栓塞术与传统化疗术疗效对比, objectType=article, longId=128635, objectId=0c75128635b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c75128635b5, replyNumber=0, likeNumber=32, createdTime=2018-05-01, rootId=0, userName=ms5822920152752585, userId=6bf82500013, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c75128635b5, moduleTitle=Radiology：肝细胞肝癌消融化疗栓塞术与传统化疗术疗效对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c75128635b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984592, encodeId=f87b19845923e, content=<a href='/topic/show?id=40d93356656' target=_blank style='color:#2F92EE;'>#化疗栓塞#</a>, objectTitle=Hepatology：在治疗中晚期肝癌患者中，原发性肝切除术(PH)优于经动脉化疗栓塞(TACE), objectType=article, longId=132930, objectId=3f1b13293054, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f1b13293054, replyNumber=0, likeNumber=40, createdTime=2018-11-22, rootId=0, userName=ms5822920152752585, userId=6bf82500013, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f1b13293054, moduleTitle=Hepatology：在治疗中晚期肝癌患者中，原发性肝切除术(PH)优于经动脉化疗栓塞(TACE), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f1b13293054)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984590, encodeId=681e19845903c, content=<a href='/topic/show?id=40d93356656' target=_blank style='color:#2F92EE;'>#化疗栓塞#</a>, objectTitle=动脉化疗栓塞和Y-90治疗肝细胞癌, objectType=article, longId=45433, objectId=519345433ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=519345433ea, replyNumber=0, likeNumber=36, createdTime=2015-02-25, rootId=0, userName=ms5822920152752585, userId=6bf82500013, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=519345433ea, moduleTitle=动脉化疗栓塞和Y-90治疗肝细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=519345433ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984589, encodeId=c92119845899a, content=<a href='/topic/show?id=40d93356656' target=_blank style='color:#2F92EE;'>#化疗栓塞#</a>, objectTitle=门静脉化疗栓塞预防肝癌切除术后复发, objectType=article, longId=5866, objectId=2a84586637, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a84586637, replyNumber=0, likeNumber=40, createdTime=2013-03-07, rootId=0, userName=ms5822920152752585, userId=6bf82500013, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a84586637, moduleTitle=门静脉化疗栓塞预防肝癌切除术后复发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a84586637)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

化疗栓塞

2020-05-29

ms5822920152752585 (审核中...)

前往app查看评论内容

#化疗栓塞#

J Clin Oncol：乐伐替尼联合经动脉化疗栓塞可显著改善晚期肝癌患者预后

2022-12-06

ms5822920152752585 (审核中...)

前往app查看评论内容

#化疗栓塞#

Eur J Cancer：采用顺铂或表柔比星进行动脉化疗栓塞治疗肝癌的疗效

2022-08-30

ms5822920152752585 (审核中...)

前往app查看评论内容

#化疗栓塞#

JGH：肿瘤负荷评分可以作为肝细胞癌患者接受经动脉化疗栓塞术的新预后标志物

2022-09-28

ms5822920152752585 (审核中...)

前往app查看评论内容

#化疗栓塞#

Liver Cancer：仑伐替尼联合或不联合药物洗脱微球经动脉化疗栓塞治疗不可切除晚期肝细胞癌的疗效

2022-10-27

ms5822920152752585 (审核中...)

前往app查看评论内容

#化疗栓塞#

更新！看更新版《中国肝细胞癌经动脉化疗栓塞治疗临床实践指南》谈接受介入治疗的HCC患者抗HBV治疗

2022-08-19

ms5822920152752585 (审核中...)

前往app查看评论内容

#化疗栓塞#

Liver Cancer：Lenvatinib(仑伐替尼)初始治疗出现应答是仑伐替尼（LEN)+经动脉化疗栓塞(LEN-TACE)序贯治疗的预后指标

2022-11-24

ms5822920152752585 (审核中...)

前往app查看评论内容

#化疗栓塞#

Eur Radiol：肝癌累及了肝静脉或下腔静脉，经动脉化疗栓塞后总生存率怎么样？

2021-12-18

ms5822920152752585 (审核中...)

前往app查看评论内容

#化疗栓塞#

Clinica Chimica Acta：可溶性程序性死亡配体1水平升高表明肝细胞癌患者接受经导管动脉化疗栓塞后免疫抑制和预后不良

2021-02-06

ms5822920152752585 (审核中...)

前往app查看评论内容

#化疗栓塞#

TAG: 辅助性经导管动脉化疗栓塞术在肝癌肝切除患者中的有效性分析

2021-02-14

ms5822920152752585 (审核中...)

前往app查看评论内容

#化疗栓塞#

Brit J Surg：肝细胞癌患者经动脉化疗栓塞术后的肝移植结局

2020-08-22

ms5822920152752585 (审核中...)

前往app查看评论内容

#化疗栓塞#

Clinica Chimica Acta：新辅助介入化疗栓塞后宫颈鳞癌基因表达的变化

2020-06-02

ms5822920152752585 (审核中...)

前往app查看评论内容

#化疗栓塞#

中国肝细胞癌经动脉化疗栓塞治疗（TACE）临床实践指南

2019-03-27

ms5822920152752585 (审核中...)

前往app查看评论内容

#化疗栓塞#

Hepatology：在中-晚期肝癌患者中，肝切除和化疗栓塞两种治疗方法的比较

2019-09-09

ms5822920152752585 (审核中...)

前往app查看评论内容

#化疗栓塞#

CLIN CANCER RES：HBV相关肝细胞癌切除后辅助动脉化疗栓塞治疗

2018-07-03

ms5822920152752585 (审核中...)

前往app查看评论内容

#化疗栓塞#

中国肝细胞癌经动脉化疗栓塞治疗临床实践指南发布

2018-11-07

智智灵药 (审核中...)

前往app查看评论内容

#化疗栓塞#

肝癌化疗栓塞后溶瘤综合征1例

2019-01-10

ms5822920152752585 (审核中...)

前往app查看评论内容

#化疗栓塞#

Radiology：肝细胞肝癌消融化疗栓塞术与传统化疗术疗效对比

2018-05-01

ms5822920152752585 (审核中...)

前往app查看评论内容

#化疗栓塞#

Hepatology：在治疗中晚期肝癌患者中，原发性肝切除术(PH)优于经动脉化疗栓塞(TACE)

2018-11-22

ms5822920152752585 (审核中...)

前往app查看评论内容

#化疗栓塞#

动脉化疗栓塞和Y-90治疗肝细胞癌

2015-02-25

ms5822920152752585 (审核中...)

前往app查看评论内容

#化疗栓塞#

门静脉化疗栓塞预防肝癌切除术后复发

2013-03-07

科室
- - 订阅+
  - 更多科室
工具
服务